MXCT vs OKE
MaxCyte Inc (MXCT) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
MXCT currently screens at market cap $124.3M. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the MXCT and OKE stock pages for the full models.
Not investment advice.